RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 11..13 of 13 - per page Previous page
Order by
2.5 mg and 5 mg Zolmitriptan ODF
Zolmitripan Oral Dispersible Film (ODF) is a a novel, non-mucoadhesive, fast dissolving oral dosage form of Zolmitriptan More
Immurin (Cyclosporine A)
immuno-suppresant agent More
Bestnem
Bestnem(Imipenem and cilastatin ) More
Displaying 11..13 of 13 - per page Previous page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
Generics Market Outlook: 2015
Oct 2010 - 112 pages - $7,600
Generics in Asia-Pacific
Sep 2011 - 39 pages - $250
Generics in Asia-Pacific
Sep 2010 - 37 pages - $250
Par Pharmaceutical Generics Company Intelligence Report
Jan 2011 - 20 pages - $340
Teva Pharmaceutical Industries Generics Company Intelligence Report
Jan 2011 - 54 pages - $340
Generics in Japan
Sep 2011 - 40 pages - $250
Global Generics
Sep 2011 - 42 pages - $250
Generics in Japan
Sep 2010 - 38 pages - $250
Generics in Canada
Sep 2010 - 37 pages - $250
Generics in the Netherlands
Sep 2011 - 43 pages - $250
More Related Market Research Reports >>>

Your selection

Industry sector
Pharmaceutical del
Generics del
Development phase
Phase II del

Visit also genericlicensing.com

The website which helps the generic industry do business. Visit now

Browse By

Therapeutic target
Accident and Trauma
Allergy
Blood and forming organs
Cardiovascular
Central Nervous System
Dermatological
Endocrinology
Gastrointestinal
Genetic disorders
Genito-urinary
Hospital and Surgery
Immune related disorders
Infectious diseases
Metabolism
Musculoskeletal
Oncology
Oral Health
Other therapeutic
Respiratory
Sensory organ

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us